DarioHealth (NASDAQ:DRIO) Stock Price Passes Below 200-Day Moving Average – Here’s What Happened

DarioHealth Corp. (NASDAQ:DRIO)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $9.71 and traded as low as $7.00. DarioHealth shares last traded at $7.06, with a volume of 5,075 shares trading hands.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on DRIO shares. Stifel Nicolaus reiterated a “buy” rating and set a $10.00 price target on shares of DarioHealth in a report on Thursday, May 14th. TD Cowen restated a “hold” rating and issued a $11.00 price objective on shares of DarioHealth in a report on Wednesday, May 13th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, DarioHealth has an average rating of “Hold” and an average target price of $10.50.

DarioHealth Price Performance

The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.62 and a current ratio of 3.07. The stock has a market cap of $51.61 million, a PE ratio of -0.80 and a beta of 1.11. The stock’s 50-day moving average is $7.62 and its two-hundred day moving average is $9.71.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. XTX Topco Ltd grew its stake in shares of DarioHealth by 229.0% in the second quarter. XTX Topco Ltd now owns 62,511 shares of the company’s stock valued at $42,000 after buying an additional 43,513 shares in the last quarter. Geode Capital Management LLC lifted its stake in DarioHealth by 167.9% during the 4th quarter. Geode Capital Management LLC now owns 49,567 shares of the company’s stock worth $564,000 after acquiring an additional 31,063 shares in the last quarter. Finally, Kestra Advisory Services LLC acquired a new position in DarioHealth during the 4th quarter worth about $35,000. 33.39% of the stock is currently owned by hedge funds and other institutional investors.

DarioHealth Company Profile

DarioHealth (NASDAQ:DRIO) is a digital health company specializing in chronic disease management through a smartphone-based care platform. Its core solution combines connected devices—such as glucose meters, blood pressure monitors and smart scales—with real-time data analytics and personalized coaching. The platform is designed to support individuals living with diabetes, hypertension, weight management challenges and other cardiometabolic conditions, offering continuous monitoring, tailored insights and behavioral nudges aimed at improving clinical outcomes.

The Dario platform integrates artificial intelligence and machine learning to deliver personalized guidance and education.